Repligen Corporation develops, manufactures, and sells products used to enhance the interconnected phases of the biological drug manufacturing process in North America, Europe, APAC, and internationally.
Fair value; $ 250
Average yearly return: 53%, year after year
Ranking: #45 / 52
"MyList" contains stocks which returned in average, at least 30% year after year during last 5 consecutive years.
29-10-2021 om 01:14
geschreven door wivado